EUVIMEDEUVIMED entdecken
Crossref

Antibacterial activity of a silver-incorporated vancomycin-modified mesoporous silica against methicillin-resistant Staphylococcus aureus

Mehdi Chamani, Shadi Asgari, Ali Najmeddin, Ali Pourjavadi, Mohsen Amin, Mahdi Gholami, Farid Abedin Dorkoosh iD

Journal of Biomaterials Applications · 2024

DOI: 10.1177/08853282241274517 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomaterials Applications, 2024. Verfasst von Mehdi Chamani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Vancomycin, Silicon Dioxide, Anti-Bacterial Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: Tehran University of Medical Sciences, Sharif University ofTechnology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since conventional antibiotics are almost ineffective on methicillin-resistant Staphylococcus aureus (MRSA) strains, designing their antibacterial alternatives is necessary. Besides, the use of vancomycin is applied for specific detection of the bacteria. Silver-incorporated vancomycin-modified mesoporous silica nanoparticles (MSNs@Van@Ag NPs) were designed for detection and treatment of MRSA bacteria. Mesoporous silica nanoparticles (MSNs) were synthesized through the template method, modified with vancomycin, and finally incorporated with silver nanoparticles (Ag NPs). The MSNs@Van@Ag NPs with a homogenously spherical shape, average size of 50-100 nm, surface area of 955.8 m 2 /g, and thermal stability up to 200°C were successfully characterized. The amount of Ag incorporated into the MSNs@Van@Ag was calculated at 3.9 ppm and the release amount of Ag was received at 2.92 ppm (75%) after 100 h. The in vitro antibacterial susceptibility test showed the MIC of 100 μg mL −1 for MSNs@Van and 50 μg mL −1 for MSNs@Van@Ag, showing in vitro enhanced effect of Ag and vancomycin in the bactericidal process. An in vivo acute pneumonia model was performed and biochemical assays and pathological studies confirmed the nanomedicine’s short-term safety for in vivo application. Cytokine assay using ELISA showed that MSN@Van@Ag causes a reduction of pro-inflammatory cytokines and bacterial proliferation leading to alleviation of inflammatory response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusVancomycinSilicon DioxideAnti-Bacterial AgentsSilverMicrobial Sensitivity TestsMetal NanoparticlesAnimalsPorosityMiceStaphylococcal InfectionsHumans

Stichwörter der Autor:innen

Mesoporous silicaantibacterial activitymethicillin-resistant staphylococcus aureussilvervancomycin

Substanzen

VancomycinSilicon DioxideAnti-Bacterial AgentsSilver

Autor:innen und Institutionen

  • Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Polymer Research Laboratory, Department of Chemistry, Sharif University of Technology, Tehran, Iran.
  • Department of Drug and Food Control, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Pharmaceutical Microbiology Group, Pharmaceutical Quality Assurance Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Toxicology & Pharmacology, Faculty of Pharmacy, Toxicology and Poisoning Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Medical Biomaterial Research Center (MBRC), Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Farid Abedin Dorkoosh

Förderung

  • Tehran University of Medical Sciences
  • Sharif University ofTechnology

Zitieren

APA

Chamani, M., Asgari, S., Najmeddin, A., Pourjavadi, A., Amin, M., Gholami, M., & Dorkoosh, F. A. (2024). Antibacterial activity of a silver-incorporated vancomycin-modified mesoporous silica against methicillin-resistant Staphylococcus aureus. Journal of Biomaterials Applications. https://doi.org/10.1177/08853282241274517

Vancouver

Chamani M, Asgari S, Najmeddin A, Pourjavadi A, Amin M, Gholami M, et al. Antibacterial activity of a silver-incorporated vancomycin-modified mesoporous silica against methicillin-resistant Staphylococcus aureus. Journal of Biomaterials Applications. 2024. doi:10.1177/08853282241274517

BibTeX
@article{Chamani2024,
  author = {Chamani, Mehdi and Asgari, Shadi and Najmeddin, Ali and Pourjavadi, Ali and Amin, Mohsen and Gholami, Mahdi and Dorkoosh, Farid Abedin},
  title = {Antibacterial activity of a silver-incorporated vancomycin-modified mesoporous silica against methicillin-resistant Staphylococcus aureus},
  journal = {Journal of Biomaterials Applications},
  year = {2024},
  doi = {10.1177/08853282241274517}
}
Kostenlos starten →